Valuation: Sandu Pharmaceuticals Limited

Market Cap 353M 3.67M 3.26M 3.04M 2.77M 5.22M 5.3M 36.83M 14.26M 180M 13.76M 13.46M 577M P/E 2025
30.6x
P/E 2026 16.7x
Enterprise Value 289M 3M 2.66M 2.49M 2.27M 4.27M 4.33M 30.12M 11.66M 147M 11.25M 11.01M 472M EV / Sales 2025
0.67x
EV / Sales 2026 0.33x
Free-Float
34.42%
Yield 2025
1.63%
Yield 2026 3.28%
09-11 Sandu Pharmaceuticals Limited Approves Appointment of Neeti Madan Kapre as Non Executive Independent Director, Effective 11 July 2026 CI
09-11 Sandu Pharmaceuticals Limited Approves Re-Designation of Balram Viswanathan as Managing Director, Effective from 11 July 2026 CI
08-11 Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
06-19 Sandu Pharmaceuticals Limited Announces Demise of Umesh Sandu, Member of Audit Committee and Stakeholders Relationship Committee CI
06-19 Sandu Pharmaceuticals Limited Announces the Demise of Umesh Sandu, Managing Director CI
05-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-05 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended 31 March 2026 CI
02-06 Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-12 Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
30/09/25 Sandu Pharmaceuticals Limited Approves the Continuation of Shri Vijay Kajarakar as Chief Financial Officer CI
13/08/25 Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
29/05/25 Sandu Pharmaceuticals Posts INR3.3 Million Profit in Fiscal Q4 MT
28/05/25 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025, on or Before October 25, 2025 CI
1 day+0.91%
1 week-1.27%
Current month+0.91%
1 month-4.67%
3 months-11.66%
6 months+8.43%
Current year-2.40%
1 week 35.3
Extreme 35.3
37.8
1 month 35.2
Extreme 35.2
39.5
Current year 30
Extreme 30
50
1 year 30
Extreme 30
50
3 years 30
Extreme 30
85
5 years 30
Extreme 30
86
10 years 10.45
Extreme 10.45
86
Manager TitleAgeSince
Chief Executive Officer 58 11/07/2026
Director of Finance/CFO - 30/03/2024
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 62 01/06/2011
Chairman 58 30/03/2024
Director/Board Member 69 14/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%-1.27%-20.86%-50.70% 3.67M
+0.60%-2.10%+41.32%+115.25% 1,025B
-0.33%-5.05%+38.47%+65.99% 623B
-0.02%-1.55%+10.01%+75.53% 459B
-0.40%-3.40%+60.56%+40.15% 355B
-0.73%-3.80%+21.91%+39.73% 336B
-1.46%-2.77%+11.98%+24.75% 270B
-1.16%-5.01%-4.26%+8.89% 247B
-0.67%-2.27%+36.24%+52.15% 220B
-1.02%-3.01%+32.40%+97.54% 183B
Average -0.40%-1.98%+22.78%+46.93% 371.82B
Weighted average by Cap. -0.27%-2.25%+31.16%+69.86%

Financials

2025 2026
Net sales 672M 6.98M 6.2M 5.8M 5.28M 9.94M 10.08M 70.13M 27.15M 342M 26.2M 25.63M 1.1B 699M 7.26M 6.45M 6.03M 5.5M 10.35M 10.49M 72.99M 28.25M 356M 27.27M 26.68M 1.14B
Net income 15.52M 161K 143K 134K 122K 230K 233K 1.62M 627K 7.9M 605K 592K 25.38M 17.66M 183K 163K 152K 139K 261K 265K 1.84M 714K 9M 689K 674K 28.89M
Net Debt -21.76M -226K -201K -188K -171K -322K -326K -2.27M -879K -11.08M -848K -830K -35.59M -64.37M -669K -594K -555K -506K -953K -966K -6.72M -2.6M -32.78M -2.51M -2.46M -105M
Logo Sandu Pharmaceuticals Limited
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
Employees
258
Date Price Change Volume
01/10/26 ₹36.53 +0.91% 619
30/09/26 ₹36.20 +1.00% 1,707
29/09/26 ₹35.84 -1.81% 1,265
28/09/26 ₹36.50 -1.35% 1,084
25/09/26 ₹37.00 0.00% 1,625
  1. Stock Market
  2. Stocks
  3. SANDUPHQ6 Stock